Literature DB >> 10065020

Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.

R A Archbold1, A D Timmis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10065020      PMCID： PMC1728874          DOI： 10.1136/hrt.80.6.543

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  56 in total

Review 1.  Matrix metalloproteinases and cardiovascular disease.

Authors:  C M Dollery; J R McEwan; A M Henney
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

Review 2.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

Review 3.  Vascular mechanics for the cardiologist.

Authors:  R T Lee; R D Kamm
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

4.  Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis.

Authors:  M A Pech-Amsellem; I Myara; M Storogenko; K Demuth; A Proust; N Moatti
Journal:  Cardiovasc Res       Date:  1996-06       Impact factor: 10.787

5.  Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.

Authors:  A M Zeiher; V Schächinger; J Minners
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

6.  Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation.

Authors:  Y Ikari; K Hara; T Tamura; F Saeki; T Yamaguchi
Journal:  Am J Cardiol       Date:  1995-07-15       Impact factor: 2.778

7.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Authors:  A C van der Wal; A E Becker; C M van der Loos; P K Das
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

8.  Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.

Authors:  M Shiomi; T Ito; T Tsukada; T Yata; Y Watanabe; Y Tsujita; M Fukami; J Fukushige; T Hosokawa; A Tamura
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

9.  Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

Authors:  L Lacoste; J Y Lam; J Hung; G Letchacovski; C B Solymoss; D Waters
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

10.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

Authors:  T J Anderson; I T Meredith; A C Yeung; B Frei; A P Selwyn; P Ganz
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245
View more
  3 in total

Review 1.  Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

Authors:  Chao-Yung Wang; Ping-Yen Liu; James K Liao
Journal:  Trends Mol Med       Date:  2008-01       Impact factor: 11.951

2.  Statins improve human coronary atherosclerotic plaque morphology.

Authors:  Stephanie D Reilly; Silvio H Litovsky; Michael P Steinkampf; James B Caulfield
Journal:  Tex Heart Inst J       Date:  2008

3.  Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.

Authors:  Damalie Nakanjako; Isaac Ssinabulya; Rose Nabatanzi; Lois Bayigga; Agnes Kiragga; Moses Joloba; Pontiano Kaleebu; Andrew D Kambugu; Moses R Kamya; Rafick Sekaly; Alison Elliott; Harriet Mayanja-Kizza
Journal:  Trop Med Int Health       Date:  2015-01-06       Impact factor: 2.622
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.